Buy & Sell TeraWulf Inc (WULF) – TeraWulf Inc Price Today
Aura AI Summary
Key Stats
- $11.89BMarket Cap
- TechnologySector
- -18.74%3M Drawdown
- $14.58BEnterprise Value
- -Dividend Yield
- 74% Buy | 26% SellTrading Activity
- 9 daysTypical Hold Time
TeraWulf Inc (WULF) is currently valued at a market capitalization of $11.89B, with an enterprise value of $14.58B. Over the past 52 weeks, TeraWulf Inc has traded between a low of $3.57 and a high of $26.74, highlighting its annual price range. Over the past three months, TeraWulf Inc has recorded a drawdown of -18.74%, reflecting recent price volatility. On average, investors hold TeraWulf Inc for approximately 9 days, indicating typical investor behavior on the platform.
About TeraWulf Inc
TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Most Recent News
Tesla's robotaxi fleet shrinks amid safety concerns; SpaceX IPO filing hints at major equity moves.
Tesla has reduced its robotaxi fleet to about 20 vehicles despite expanding the Austin service area, raising safety concerns from former engineers. Meanwhile, SpaceX updated its IPO filing, indicating a lock-in period for Musk's shares and potential ...

AI boom drives strong earnings beats, policy debates, and major tech moves worldwide
Recent financial reports show strong earnings beats driven by surging demand for artificial intelligence (AI) technologies, with companies like ServiceTitan, Palo Alto Networks, and CrowdStrike exceeding revenue and earnings estimates. Policymakers i...

Foundayo leads to significant weight loss in menopausal women, including those with type 2 diabetes, in clinical trials.
Eli Lilly's Foundayo (orforglipron) showed significant weight loss results in women across all menopause stages in the ATTAIN-1 and ATTAIN-2 trials, including those with type 2 diabetes. Women lost up to 30.4 lbs (14.4%) in perimenopause and up to 28...
